Free Trial

Heron Therapeutics (HRTX) Insider Trading & Ownership

Heron Therapeutics logo
$1.40 +0.08 (+6.06%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.44 +0.04 (+2.79%)
As of 08/22/2025 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Heron Therapeutics (NASDAQ:HRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.86%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$6.23M
Number Of
Insiders Selling
(Last 12 Months)
0
Get HRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Heron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HRTX Insider Buying and Selling by Quarter

Heron Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2025Adam MorganDirectorBuy1,766,546$1.50$2,649,819.00  
8/8/2025Rubric Capital Management LpMajor ShareholderBuy2,387,225$1.50$3,580,837.50  
(Data available from 1/1/2013 forward)

HRTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Heron Therapeutics includes Adam Morgan, Craig A Collard, Ira Duarte, Rubric Capital Management Lp, and William P Forbes. Learn more on insiders at HRTX.

5.86% of Heron Therapeutics stock is owned by insiders. Learn more on HRTX's insider holdings.

The following insiders have purchased HRTX shares in the last 24 months: Adam Morgan ($2,649,819.00), Craig A Collard ($138,000.00), Ira Duarte ($75,650.00), Rubric Capital Management Lp ($3,580,837.50), and William P Forbes ($47,000.00).

Insiders have purchased a total of 4,438,771 HRTX shares in the last 24 months for a total of $6,491,306.50 bought.

Heron Therapeutics Key Executives

  • Mr. Craig Alexander Collard (Age 58)
    CEO & Director
  • Ms. Ira DuarteMs. Ira Duarte (Age 55)
    Executive VP & CFO
  • Mr. Ryan Craig
    Vice President of Marketing
  • Mr. Sean T. Ristine (Age 54)
    Senior Vice President of Human Resources
  • Mr. Robert Sullivan (Age 46)
    Senior VP of Oncology Care Franchise & Commercial Operations
  • Dr. William P. Forbes Pharm. D. (Age 62)
    Pharm.D., Executive VP & Chief Development Officer
  • Jeff Cohn
    Executive Director, Assistant General Counsel & Assistant Secretary


This page (NASDAQ:HRTX) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners